Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

February newsletter Julia’s insights

Julia Lee
February 24, 2017

CEO interview – Cobalt Blue

Bell Direct
February 21, 2017

Your Money Your Call

Julia Lee
February 14, 2017

Your Money Your Call

Julia Lee
February 7, 2017

January review

Julia Lee
January 27, 2017

Superannuation Reforms

Bell Direct
January 16, 2017

Market Update

Julia Lee
January 16, 2017

Market Update

Julia Lee
January 13, 2017

Market Update 12 Jan

Julia Lee
January 12, 2017